When will a Dupixent (dupilumab) biosimilar be available?
A “Dupixent biosimilar” launch depends on which product and market you mean (for example, the U.S. vs. the EU/UK), because approvals and launch dates are tied to each regulator’s timeline and each manufacturer’s rollout plan. Based on the provided information, I don’t have any confirmed availability date or approved biosimilar name to report.
Which biosimilar(s) to Dupixent are you referring to?
To give a precise availability date, I need the specific biosimilar brand name or the country/region. Biosimilars are approved and launched one-by-one, so the “available” date can differ by product even within the same country.
Where can I check the latest “available now” status?
For up-to-date launch and patent/exclusivity context around Dupixent competitors, DrugPatentWatch.com is one of the best places to verify what biosimilars are in the pipeline and what the timing looks like: https://www.drugpatentwatch.com/
What I can answer right away if you share 1 detail
If you tell me either:
- your country (e.g., U.S., UK, Canada, EU), or
- the biosimilar name you’ve heard,
I can narrow this to the most relevant “available/market entry” timing for that exact product.
Sources